Drug Trial Radar · NCT00660660
Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US
Last checked: Nov 20, 2026Latest source record: Mar 2, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
276
Actual
Start
Apr 2008
Primary completion
Jul 2008
Study completion Jul 2008
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Apr 17, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to compare the safety and effectiveness (how well the medicine works) of esomeprazole (study drug) to placebo (a capsule that does not contain any medication) taken daily in relieving nighttime heartburn and problems sleeping in patients with gastroesophageal reflux disease (GERD).
Conditions
- Gastroesophageal Reflux Disease
Interventions
EsomeprazoleDrug
Nexium 20 mg administered once daily as 22.3 mg of esomeprazole magnesium hydrate
PlaceboDrug
once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients With Relief of Nighttime Heartburn During the Last 7 Days of the Study.Time frame: Days 21- 28 (for early dropouts the last 7 days staying in the study)
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Huntsville, Alabama
Research Site
Tucson, Arizona
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Burbank, California
Research Site
Castro Valley, California
Research Site
Orange, California
Research Site
San Diego, California
Research Site
Boynton Beach, Florida
Research Site
Coral Springs, Florida
Research Site
DeLand, Florida
Research Site
Hollywood, Florida
Research Site
Jupiter, Florida
Research Site
Pembroke Pines, Florida
Research Site
South Miami, Florida
Research Site
Tampa, Florida
Research Site
Zephyrhills, Florida
Research Site
Stockbridge, Georgia
Research Site
Overland Park, Kansas
Research Site
Lexington, Kentucky
Research Site
Hollywood, Maryland
Research Site
Las Vegas, Nevada
Research Site
Medford, New Jersey
Research Site
Perth Amboy, New Jersey
Research Site
West Orange, New Jersey
Research Site
Albuquerque, New Mexico
Research Site
Binghamton, New York
Research Site
Huntersville, North Carolina
Research Site
Raleigh, North Carolina
Research Site
Winston-Salem, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Dayton, Ohio
Research Site
Kettering, Ohio
Research Site
Oklahoma City, Oklahoma
Research Site
Chattanooga, Tennessee
Research Site
Johnson City, Tennessee
Research Site
Amarillo, Texas
Research Site
Fort Worth Dallas, Texas
Research Site
Houston, Texas
Research Site
Ogden, Utah
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.